Syschem (India) Ltd

Syschem (India) Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Syschem (India) Ltd

₹ 40.2 0.83%
22 Nov - close price
syschem.in BSE: 531173
About

Incorporated in 1993, Syschem (India) Limited manufactures Active Pharmaceuticals Ingredients (APIs) and bulk drugs.

Key Points

Product Profile:[1]
API/ Intermediates:
a) Amoxycillin Tri Hydrate
b) Ampicillin Tri Hydrate
c) Cloxacillin Sodium
d) Dicloxacillin Sodium
e) Flucloxacillin Sodium (For export only)
f) Cephalexin
g) Cefixime
h) Cefadroxil
i) Distillation of Specialty Solvents –
DMF, Acetonitrile, Ethyl Acetate and THF

Website BSE
  • Market Cap ₹ 160 Cr.
  • Current Price ₹ 40.2
  • High / Low ₹ 73.9 / 37.2
  • Stock P/E
  • Book Value ₹ 14.2
  • Dividend Yield 0.00 %
  • ROCE 10.7 %
  • ROE 6.97 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company is expected to give good quarter

Cons

  • Stock is trading at 2.84 times its book value
  • Though the company is reporting repeated profits, it is not paying out dividend
  • Promoter holding has decreased over last quarter: -0.72%
  • Company has a low return on equity of 9.29% over last 3 years.
  • Debtor days have increased from 93.7 to 126 days.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
11.30 10.20 20.08 15.10 20.02 29.52 48.91 43.10 37.11 43.74 74.71 87.53 47.52
12.38 10.57 17.21 13.75 18.08 26.68 46.39 40.65 35.26 42.66 73.09 86.72 47.45
Operating Profit -1.08 -0.37 2.87 1.35 1.94 2.84 2.52 2.45 1.85 1.08 1.62 0.81 0.07
OPM % -9.56% -3.63% 14.29% 8.94% 9.69% 9.62% 5.15% 5.68% 4.99% 2.47% 2.17% 0.93% 0.15%
0.02 0.04 0.06 0.05 0.13 0.01 0.06 0.00 0.00 0.01 0.15 0.01 0.00
Interest 0.02 0.03 0.22 0.01 0.02 0.06 -0.04 0.10 0.03 0.11 0.01 0.00 0.03
Depreciation 0.63 0.63 0.69 0.68 0.71 0.71 0.59 0.68 0.70 0.74 0.67 0.68 0.68
Profit before tax -1.71 -0.99 2.02 0.71 1.34 2.08 2.03 1.67 1.12 0.24 1.09 0.14 -0.64
Tax % 0.00% 0.00% -23.27% 0.00% 0.00% 0.00% 80.79% 0.00% 0.00% 0.00% 123.85% 0.00% 0.00%
-1.71 -0.99 2.49 0.71 1.34 2.07 0.39 1.68 1.12 0.23 -0.26 0.14 -0.64
EPS in Rs -0.59 -0.34 0.86 0.19 0.35 0.52 0.10 0.42 0.28 0.06 -0.07 0.04 -0.16
Raw PDF

Profit & Loss

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
16 18 11 4 13 67 93 77 68 59 114 199 254
12 14 14 5 12 63 89 77 73 58 105 192 250
Operating Profit 4 4 -3 -1 0 3 4 -0 -5 1 9 7 4
OPM % 24% 22% -23% -24% 0% 5% 4% -0% -7% 1% 8% 4% 1%
0 1 0 0 -0 -0 -0 0 -0 0 0 0 0
Interest 1 3 1 0 0 0 0 0 0 0 0 0 0
Depreciation 1 2 2 2 2 2 2 2 2 3 3 3 3
Profit before tax 1 1 -5 -3 -2 1 2 -2 -7 -2 6 4 1
Tax % 29% 21% -26% -27% -30% 43% 50% -16% -24% -22% 27% 33%
1 1 -4 -2 -1 0 1 -2 -6 -2 5 3 -1
EPS in Rs 0.49 0.30 -1.94 -1.13 -0.75 0.17 0.32 -0.79 -2.07 -0.59 1.13 0.69 -0.13
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 0%
Compounded Sales Growth
10 Years: 27%
5 Years: 16%
3 Years: 43%
TTM: 60%
Compounded Profit Growth
10 Years: 17%
5 Years: 23%
3 Years: 36%
TTM: -110%
Stock Price CAGR
10 Years: 20%
5 Years: 43%
3 Years: 49%
1 Year: -21%
Return on Equity
10 Years: -6%
5 Years: -2%
3 Years: 9%
Last Year: 7%

Balance Sheet

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 16 16 16 16 16 16 19 19 22 23 32 40 40
Reserves -3 -2 -6 -8 -10 -9 -8 -10 -16 -17 -10 17 17
31 32 28 27 22 20 16 17 16 2 2 0 0
4 9 13 12 16 30 36 36 55 52 69 107 61
Total Liabilities 48 55 51 47 44 58 62 62 77 60 93 164 117
29 36 34 32 30 29 27 28 30 32 31 31 30
CWIP 4 0 1 1 1 0 0 1 1 0 0 4 19
Investments 0 0 0 0 0 0 0 0 0 0 0 0 0
14 18 16 15 14 28 35 34 46 28 62 129 68
Total Assets 48 55 51 47 44 58 62 62 77 60 93 164 117

Cash Flows

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
4 4 1 0 6 0 -2 3 4 1 -8 -26
-13 -3 0 0 0 0 2 -4 -4 -1 -2 -6
10 -1 -2 -1 -7 -0 -0 -0 -0 -0 11 32
Net Cash Flow 1 0 -1 0 -0 0 0 -0 -0 0 1 -0

Ratios

Figures in Rs. Crores

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 115 143 187 272 124 47 21 47 31 21 135 126
Inventory Days 214 280 228 868 182 80 104 110 199 152 61 107
Days Payable 56 183 290 870 424 151 131 175 221 186 158 198
Cash Conversion Cycle 273 240 124 271 -119 -24 -7 -19 9 -14 38 34
Working Capital Days 108 120 72 92 -173 -23 -12 -24 13 -15 48 54
ROCE % 8% 8% -11% -8% -6% 3% 8% -8% -29% -13% 39% 11%

Shareholding Pattern

Numbers in percentages

7 Recently
Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
16.34% 16.34% 21.78% 52.10% 53.82% 53.82% 53.82% 53.79% 53.89% 53.89% 53.89% 53.17%
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.14% 0.25% 0.25% 0.20%
83.66% 83.66% 78.22% 47.90% 46.18% 46.19% 46.19% 46.21% 45.97% 45.86% 45.87% 46.63%
No. of Shareholders 8,3598,3968,3709,3189,16710,18110,32912,18612,57113,94213,31013,305

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Concalls

  • May 2023
    Transcript
    Notes
    PPT
  • Nov 2022
    Transcript
    Notes
    PPT
  • Jul 2022
    Transcript
    Notes
    PPT